Suppr超能文献

The novel coronavirus (COVID-19) and the risk of Kawasaki disease in children.

作者信息

Alizargar Javad

机构信息

Research Center for Healthcare Industry Innovation, National Taipei University of Nursing and Health Sciences, Taipei City 112, Taiwan.

出版信息

J Formos Med Assoc. 2020 Nov;119(11):1713-1714. doi: 10.1016/j.jfma.2020.05.030. Epub 2020 May 23.

Abstract
摘要

相似文献

1
The novel coronavirus (COVID-19) and the risk of Kawasaki disease in children.新型冠状病毒(COVID-19)与儿童川崎病风险
J Formos Med Assoc. 2020 Nov;119(11):1713-1714. doi: 10.1016/j.jfma.2020.05.030. Epub 2020 May 23.
2
Kawasaki disease epidemic: pitfalls.川崎病流行:陷阱。
Ital J Pediatr. 2020 Aug 27;46(1):121. doi: 10.1186/s13052-020-00887-4.
3
Incomplete Kawasaki Disease in a Child with Covid-19.一名感染新冠病毒的儿童患不完全川崎病
Indian Pediatr. 2020 Jul 15;57(7):680-681. doi: 10.1007/s13312-020-1900-0. Epub 2020 May 9.
5
Kawasaki Disease Features and Myocarditis in a Patient with COVID-19.一名新冠肺炎患者的川崎病特征与心肌炎
Pediatr Cardiol. 2020 Oct;41(7):1526-1528. doi: 10.1007/s00246-020-02393-0. Epub 2020 Jun 15.
6
COVID-19 and Kawasaki syndrome: should we really be surprised?新冠病毒与川崎病:我们真的应该感到惊讶吗?
Cardiol Young. 2020 Jul;30(7):1059-1060. doi: 10.1017/S1047951120001432. Epub 2020 Jun 25.
7
[Not Available].[无可用内容]
Rev Med Suisse. 2020 May 13;16(693):1012-1013.

引用本文的文献

2
Cytokine cascade in Kawasaki disease versus Kawasaki-like syndrome.川崎病与川崎病样综合征的细胞因子级联反应。
Physiol Res. 2022 Mar 25;71(1):17-27. doi: 10.33549/physiolres.934672. Epub 2022 Jan 19.
3
Adverse Cardiovascular Effects of Anti-COVID-19 Drugs.抗新冠病毒药物的心血管不良影响。
Front Pharmacol. 2021 Aug 25;12:699949. doi: 10.3389/fphar.2021.699949. eCollection 2021.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验